Product image of Kidiaven Nouveau-Ne 2 (Valine, Acetylcysteine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine) supplied by GNH India

Kidiaven Nouveau-Ne 2

Active Ingredient:
Valine, Acetylcysteine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine
Origin:
EU

Kidiaven Nouveau-Ne 2 (Valine, Acetylcysteine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine)

Valine, Acetylcysteine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, the active ingredient in Kidiaven Nouveau-Ne 2, is an amino acid solution presented as a solution for injection for parenteral use. It supports parenteral nutrition for infants and children who require intravenous protein supplementation.

GNH India supplies Kidiaven Nouveau-Ne 2 as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals worldwide.

Manufacturer / TM Owner

Fresenius Kabi France S.A.S.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Kidiaven Nouveau-Ne 2, an amino acid solution for parenteral nutrition, is used in pediatric patients requiring intravenous protein support.

  • Parenteral nutrition for infants: provides essential amino acids to meet growth and metabolic needs.
  • Parenteral nutrition for children: supports protein synthesis and nitrogen balance during intravenous feeding.
  • Support of growth and development in pediatric patients requiring intravenous nutrition: helps maintain adequate amino acid supply for normal development.

How It Works

  • Kidiaven Nouveau-Ne 2 delivers a balanced mixture of essential and non‑essential amino acids directly into the bloodstream. The amino acids serve as substrates for protein synthesis, replenish nitrogen stores, and support cellular metabolism. By supplying these building blocks intravenously, the solution helps maintain nitrogen balance and promotes tissue growth in patients who cannot receive enteral nutrition.

Side Effects

Adverse reactions may occur with any parenteral amino acid solution. Monitoring and prompt management are essential.

Common Side Effects

  • Hyperglycemia: elevated blood glucose levels during infusion.
  • Electrolyte imbalance: changes in serum potassium, sodium, or calcium.
  • Infusion site irritation: redness, pain, or swelling at the catheter site.
  • Mild fever: low‑grade temperature rise during therapy.

Serious or Rare Side Effects

  • Anaphylactic reaction: severe allergic response requiring immediate intervention.
  • Catheter‑related sepsis: infection associated with the intravenous line.
  • Metabolic acidosis: significant drop in blood pH due to acid accumulation.
  • Renal dysfunction: impaired kidney function potentially linked to amino acid load.

Precautions & Warnings

When using Kidiaven Nouveau-Ne 2, clinicians should observe several safety measures.

  • Dose individualization: adjust based on patient weight, renal and hepatic function.
  • Monitoring: regularly assess plasma amino acid levels, nitrogen balance, and metabolic parameters.
  • Compatibility: verify compatibility with other IV solutions before mixing.
  • Catheter care: maintain aseptic technique to prevent infection.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Kidiaven Nouveau-Ne 2 may interact with other therapies; awareness of major and moderate interactions helps prevent complications.

Major Interactions (Avoid)

  • Concurrent high‑dose amino acid solutions: risk of metabolic overload.
  • Incompatible IV fluids containing calcium or phosphate: may precipitate and cause emboli.
  • Renal replacement therapy: alters amino acid clearance and may require dose adjustment.

Moderate Interactions (Monitor Closely)

  • Insulin therapy: amino acid infusion can affect glucose control.
  • Diuretics: may influence electrolyte balance during therapy.

Frequently Asked Questions

Kidiaven Nouveau-Ne 2 is an amino acid solution designed for parenteral nutrition in infants and children. It provides a complete profile of essential and non‑essential amino acids to support protein synthesis, nitrogen balance, and overall growth when oral or enteral feeding is not possible.

The mixture supplies the body with the amino acids required for building proteins and maintaining metabolic functions. By delivering these substrates directly into the bloodstream, the solution bypasses the gastrointestinal tract, allowing rapid incorporation into cellular processes that support tissue growth and repair.

Dosing is individualized by the prescribing clinician based on the patient’s weight, age, renal and hepatic function, and overall nutritional needs. The healthcare professional calculates the appropriate volume and infusion rate to achieve the desired amino acid intake.

Safety data for use in pregnancy or lactation are limited. The product should only be used if the potential benefits to the mother or infant outweigh any possible risks, and this decision must be made by a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and import documentation.

Kidiaven Nouveau-Ne 2 offers a comprehensive blend of nine amino acids commonly used in pediatric parenteral nutrition. Compared with other formulations, it is formulated to meet the specific growth and metabolic requirements of infants and children, and it complies with EU manufacturing standards for purity and sterility.

The product must be stored refrigerated at 2‑8 °C, protected from light, and must not be frozen or shaken. It should be kept in its original packaging until use to maintain sterility and stability.

Kidiaven Nouveau-Ne 2 is administered intravenously, typically via a central or peripheral venous catheter. The solution is diluted in an appropriate compatible carrier fluid and infused over a period determined by the prescribing clinician, following aseptic technique.

Serious risks include anaphylactic reactions, catheter‑related sepsis, metabolic acidosis, and renal dysfunction. Prompt recognition of these events and immediate medical intervention are essential to mitigate harm.

Patients with known hypersensitivity to any of the amino acids in the formulation, those with severe metabolic disorders that contraindicate amino acid infusion, or individuals with uncontrolled electrolyte imbalances should not receive this product without careful clinical assessment.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Valine, Acetylcysteine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT